2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
| 热门AI工具： |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | MOLECULAR THERAPY MOL THER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.8
63人评分
我要评分
声誉 9.5 影响力 8.2 速度 9.0 | |||||||||||||||||||||||||||||||||
| 期刊ISSN | 1525-0016 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||||||
| E-ISSN | 1525-0024 | |||||||||||||||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年9月20日：7.949 | |||||||||||||||||||||||||||||||||
| 2025-2026自引率 | 3.5%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 12.698数据由网友[crystaltraveler53]收集提供 | |||||||||||||||||||||||||||||||||
| h-index | 158 | |||||||||||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||||
| 期刊官方网站 | https://www.cell.com/molecular-therapy-family/molecular-therapy/home | |||||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/molecular-therapy/default.aspx | |||||||||||||||||||||||||||||||||
| 作者指南网址 | https://www.cell.com/molecular-therapy-family/molecular-therapy/authors | |||||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Costimulatory biomarker-specific CD28 PET for early prediction of the response to PD-1 blockade in lung cancer Author: Yang, Yang; Wang, Jiannan; Yu, Hong; Quan, Zhen; Zhang, Zhujiao; Guo, Jingran; Wu, Haoxuan; Liu, Shanshan; Li, Xiaoqian; Hu, Xinxin; Zou, Hongyan; Zhu, Mengyuan; Wang, Tianyi; Zhou, Zijian; Liu, Jiaying; Wang, Jing; Wang, Kai; Yang, Lili; Han, Zhaoguo; Sun, Xilin Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4828-4843. DOI: 10.1016/j.ymthe.2026.05.011 Administration of neuritin as a novel therapeutic strategy for autoimmune and inflammatory diseases Author: Wei, Ping; Zhang, Kaimin; Hu, Yiping; Gao, Xu; Hou, Yingnan; Riaz, Farooq; Zhang, Zhenzhen; He, Juan; Zhang, Miaomiao; Li, Yikui; Li, Fangfang; Wang, Aiting; Zhao, Taowen; Zhang, Biyi; Li, Xingchi; Jiang, Anmei; Wu, Lin; Chen, Youhai H.; Fan, Zusen; Huang, Jing; Wang, Qingwen; Pan, Fan Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4880-4902. DOI: 10.1016/j.ymthe.2026.04.059 From weak but broad to potent and universal: A trispecific antibody against conserved SARS-CoV-2 spike epitopes Author: Tian, Xiaodong; Wang, Chunmei; Han, Pu; Liu, Honghui; Wu, Lili; Wang, Xiaoyun; Yu, Shufan; Zhang, Yanning; Zhao, Binbin; Liu, Jiangning; Gao, George Fu; Wang, Qihui Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4983-4997. DOI: 10.1016/j.ymthe.2026.05.012 Therapeutic bacteria-trained NK cells confer long-term protection against cancer metastasis Author: Rong, Li; Hu, Jingchu; Jin, Wei; Li, Renhao; Wu, Yangfan; Zhou, Nan; Zhao, Xiaoyu; Zhou, Zhongjun; Hosen, Md Shakhawat; Wang, Xiaolei; Han, Shuo; Gong, Huarui; Lin, Xuansheng; Li, Wenjun; He, Yige; Kim, Sukbum; Lin, Qiubin; Huang, Jian-Dong Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4708-4728. DOI: 10.1016/j.ymthe.2026.05.023 | |||||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足MOLECULAR THERAPY的语言要求，还能让MOLECULAR THERAPY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被MOLECULAR THERAPY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes (Hybrid，可自选是否OA) | |||||||||||||||||||||||||||||||||
| 通讯方式 | CELL PRESS, 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 02139 | |||||||||||||||||||||||||||||||||
| 出版商 | Cell Press | |||||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-生物工程与应用微生物 | |||||||||||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||||||||||
| 出版年份 | 2000 | |||||||||||||||||||||||||||||||||
| 年文章数 | 369点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 35.37% | |||||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 79.40% | |||||||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2025-2026年最新版） | 注册或登录后，查看WOS分区等级 | |||||||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-0016%5BISSN%5D | |||||||||||||||||||||||||||||||||
| 平均审稿速度 | 期刊官网数据： 平均Time to first decision: 8 days; 网友分享经验： 平均1月 | |||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较难 | |||||||||||||||||||||||||||||||||
| APC文章处理费信息 | 版面费：For ASGCT members: $64 per page up to eight printed pages and $128 per page thereafter, additional OA option fee is $3,600; For non-ASGCT members: $116 per page up to eight printed pages and $180 per page thereafter, OA option fee is $4,500; | |||||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在MOLECULAR THERAPY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||||
| 编辑信息 | Editor-in-Chief Joseph C. Glorioso III, PhD, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA Front matter editor John Bell, PhD, University of Ottawa, Ottawa, Canada | |||||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Costimulatory biomarker-specific CD28 PET for early prediction of the response to PD-1 blockade in lung cancer Author: Yang, Yang; Wang, Jiannan; Yu, Hong; Quan, Zhen; Zhang, Zhujiao; Guo, Jingran; Wu, Haoxuan; Liu, Shanshan; Li, Xiaoqian; Hu, Xinxin; Zou, Hongyan; Zhu, Mengyuan; Wang, Tianyi; Zhou, Zijian; Liu, Jiaying; Wang, Jing; Wang, Kai; Yang, Lili; Han, Zhaoguo; Sun, Xilin Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4828-4843. DOI: 10.1016/j.ymthe.2026.05.011 PubMed DOI |
| 2. | Administration of neuritin as a novel therapeutic strategy for autoimmune and inflammatory diseases Author: Wei, Ping; Zhang, Kaimin; Hu, Yiping; Gao, Xu; Hou, Yingnan; Riaz, Farooq; Zhang, Zhenzhen; He, Juan; Zhang, Miaomiao; Li, Yikui; Li, Fangfang; Wang, Aiting; Zhao, Taowen; Zhang, Biyi; Li, Xingchi; Jiang, Anmei; Wu, Lin; Chen, Youhai H.; Fan, Zusen; Huang, Jing; Wang, Qingwen; Pan, Fan Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4880-4902. DOI: 10.1016/j.ymthe.2026.04.059 PubMed DOI |
| 3. | From weak but broad to potent and universal: A trispecific antibody against conserved SARS-CoV-2 spike epitopes Author: Tian, Xiaodong; Wang, Chunmei; Han, Pu; Liu, Honghui; Wu, Lili; Wang, Xiaoyun; Yu, Shufan; Zhang, Yanning; Zhao, Binbin; Liu, Jiangning; Gao, George Fu; Wang, Qihui Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4983-4997. DOI: 10.1016/j.ymthe.2026.05.012 PubMed DOI |
| 4. | Therapeutic bacteria-trained NK cells confer long-term protection against cancer metastasis Author: Rong, Li; Hu, Jingchu; Jin, Wei; Li, Renhao; Wu, Yangfan; Zhou, Nan; Zhao, Xiaoyu; Zhou, Zhongjun; Hosen, Md Shakhawat; Wang, Xiaolei; Han, Shuo; Gong, Huarui; Lin, Xuansheng; Li, Wenjun; He, Yige; Kim, Sukbum; Lin, Qiubin; Huang, Jian-Dong Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4708-4728. DOI: 10.1016/j.ymthe.2026.05.023 PubMed DOI |
| 5. | Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness Author: Pang, Nengzhi; He, Jinping; Pei, Lei; Xiao, Ying; Gu, Yingying; Zhi, Cheng; Lai, Xuye; Chen, Mingtao; Xiao, Qiyao; Wu, Xueqian; Zhang, Zhenfeng; Yang, Lili Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4743-4757. DOI: 10.1016/j.ymthe.2026.05.026 PubMed DOI |
| 6. | Programmable miRNA-guided RNA-toxin switch for selective elimination of cancer cells Author: Ma, Xinghuan; Zhang, Yufeng; Liu, Sujia; Guo, Tianyu; Zhu, Xudong; Zhong, Yiming; Sun, Huanwei; Du, Shubo; Liu, Yefu; Lin, Jiaqi Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4794-4813. DOI: 10.1016/j.ymthe.2026.05.021 PubMed DOI |
| 7. | Systemic application of IL-33 for cancer immunoprevention and immunotherapy Author: Liu, Jie; Wei, Hongyan; Feng, Zhenchu; Sun, Heng; Zhang, Yuanfu; Chen, Wenlong; Li, Xiaoshi; Li, Chang; Zhang, Ying; Ke, Yixi; Wang, Minjun; Liu, Lantian; Xu, Peng; Shuai, Shimin; Chen, Xi; Jin, Shi; Liu, Quan Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4814-4827. DOI: 10.1016/j.ymthe.2026.05.009 PubMed DOI |
| 8. | Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation Author: Liao, Feng; Liu, Peng; Wu, Liumei; Zhong, Tingjing; Li, Jiaxiao; Chen, Jiafan; Wu, Chen; Liu, Ya; Chen, Junzhe; Li, Geng; Wang, Wenbiao Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4904-4920. DOI: 10.1016/j.ymthe.2026.04.062 PubMed DOI |
| 9. | Kindlin-2 functional restoration through methylmalonic acid clearance by coenzyme A counteracts osteoporosis Author: Li, Xuling; Ma, Guixing; Wang, Fen; Ding, Zhen; Chen, Yong; Cheng, Siyuan; Pang, Wei; Chen, Litong; Cao, Huiling Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4964-4982. DOI: 10.1016/j.ymthe.2026.05.015 PubMed DOI |
| 10. | Plant-derived miRNAs: Cross-kingdom anti-tumor agents and next generation of oral biopharmaceuticals Author: Jin, Wei; Li, Zhuo; Zhao, Jixiang; Li, Ying; Dong, Zhengqi Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 8, pp. 4422-4441. DOI: 10.1016/j.ymthe.2026.05.018 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共205条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
